Adam Tomasz Polonek
Corporate Officer/Principal at BIOTON S.A.
Profile
Adam Tomasz Polonek is currently the Chairman at Biopartners GmbH and the Director at M.J.
Group.
He previously served as the Member-Management Board at BIOTON SA from 2006 to the present.
Prior to that, he was the Deputy Director at Caib Financial Advisers from 2000 to 2006 and the Chief Financial Officer at SciGen Pte Ltd.
from 2008 to 2018.
Mr. Polonek obtained his undergraduate degree from Uniwersytet Ekonomiczny w Katowicach.
Adam Tomasz Polonek active positions
| Companies | Position | Start |
|---|---|---|
| BIOTON S.A. | Corporate Officer/Principal | 2011-12-19 |
M.J. Group
 M.J. Group Pharmaceuticals: MajorHealth Technology M.J. Group develops pharmaceutical products. It exports and distributes pharmaceuticals, agrochemicals, aromatic chemicals, and perfumery compounds through its subsidiaries. The company was founded by Jamal Jaffer Dewij, Abdul Jaffer Dewji and Hussein Abdulla Jaffer in 1954 and is headquartered in Mumbai, India. | Director/Board Member | - |
Biopartners GmbH
 Biopartners GmbH Pharmaceuticals: MajorHealth Technology Biopartners GmbH engages in the development of biopharmaceutical products in the fields of endocrinology, multiple sclerosis, and virology. The company was founded in 2000 and is headquartered in Baar, Switzerland. | Chairman | - |
Former positions of Adam Tomasz Polonek
| Companies | Position | End |
|---|---|---|
| SCIGEN LIMITED | Director of Finance/CFO | 2018-08-30 |
| Caib Financial Advisers | Corporate Officer/Principal | 2005-12-31 |
Training of Adam Tomasz Polonek
| Uniwersytet Ekonomiczny w Katowicach | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BIOTON S.A. | Health Technology |
| Private companies | 4 |
|---|---|
SciGen Pte Ltd.
 SciGen Pte Ltd. Pharmaceuticals: MajorHealth Technology SciGen Pte Ltd. engages in the development, manufacturing, and marketing of biopharmaceutical products. It operates through following segments: Singapore, Australia, Korea, Thailand, Philippines, China, and Others. The Singapore segment comprises of corporate office functions, sales, and marketing. The Australia, Korea, Thailand, and Philippines segments deal with sales and marketing activities. The China segment is involved in regulatory activities. The Others segment covers operations on in Indonesia, Pakistan, Vietnam, Hong Kong, Myanmar, Malaysia, and profit sharing income on sale of insulin. The firm's products include SciLin, SciTropin A, SciLocyte, SciTrace 5 Injection, and Heri Injection. The company was founded by Saul Akerib Mashaal in 1988 and is headquartered in Singapore. | Health Technology |
M.J. Group
M.J. Group Pharmaceuticals: MajorHealth Technology M.J. Group develops pharmaceutical products. It exports and distributes pharmaceuticals, agrochemicals, aromatic chemicals, and perfumery compounds through its subsidiaries. The company was founded by Jamal Jaffer Dewij, Abdul Jaffer Dewji and Hussein Abdulla Jaffer in 1954 and is headquartered in Mumbai, India. | Health Technology |
Biopartners GmbH
Biopartners GmbH Pharmaceuticals: MajorHealth Technology Biopartners GmbH engages in the development of biopharmaceutical products in the fields of endocrinology, multiple sclerosis, and virology. The company was founded in 2000 and is headquartered in Baar, Switzerland. | Health Technology |
| Caib Financial Advisers |
- Stock Market
- Insiders
- Adam Tomasz Polonek
